MDT

95.62

0%↓

VEEV

284.35

+0.48%↑

A

144.13

+1.57%↑

HQY

92.48

+1.41%↑

TLRY

1.59

+2.58%↑

MDT

95.62

0%↓

VEEV

284.35

+0.48%↑

A

144.13

+1.57%↑

HQY

92.48

+1.41%↑

TLRY

1.59

+2.58%↑

MDT

95.62

0%↓

VEEV

284.35

+0.48%↑

A

144.13

+1.57%↑

HQY

92.48

+1.41%↑

TLRY

1.59

+2.58%↑

MDT

95.62

0%↓

VEEV

284.35

+0.48%↑

A

144.13

+1.57%↑

HQY

92.48

+1.41%↑

TLRY

1.59

+2.58%↑

MDT

95.62

0%↓

VEEV

284.35

+0.48%↑

A

144.13

+1.57%↑

HQY

92.48

+1.41%↑

TLRY

1.59

+2.58%↑

Search

KemPharm Inc

Open

0

Overview

Share price change

24h

Current

Min

Max

Key metrics

By Trading Economics

Income

78M

75M

Sales

5.5M

26M

Profit margin

288.656

Employees

59

EBITDA

-73M

-71M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+120.37% upside

Dividends

By Dow Jones

Next Earnings

12 Nov 2025

Market Stats

By TradingEconomics

Market Cap

-40M

600M

Previous open

0

Previous close

0

KemPharm Inc Chart

Past performance is not a reliable indicator of future results.

Related News

27 Feb 2025, 15:29 UTC

Acquisitions, Mergers, Takeovers

Zevra Therapeutics to Sell Priority-Review Voucher for $150 Million

Peer Comparison

Price change

KemPharm Inc Forecast

Price Target

By TipRanks

120.37% upside

12 Months Forecast

Average 23.8 USD  120.37%

High 29 USD

Low 18 USD

Based on 6 Wall Street analysts offering 12 month price targets forKemPharm Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat